Somatic Mosaicism and Disease

The large number of cell divisions required to make a human body inevitably leads to the accumulation of somatic mutations. Such mutations cause individuals to be somatic mosaics. Recent advances in genomic technology now allow measurement of somatic diversity. Initial studies confirmed the expected high levels of somatic mutations within individuals. Going forward, the big questions concern the degree to which those somatic mutations influence disease. Theory predicts that the frequency of mutant cells should vary greatly between individuals. Such somatic mutational variability between individuals could explain much of the diversity in the risk of disease. But how variable is mosaicism between individuals in reality? What is the relation between the fraction of cells carrying a predisposing mutation and the risk of disease? What kinds of heritable somatic change lead to disease besides classical DNA mutations? What molecular processes connect a predisposing somatic change to disease? We know that predisposing somatic mutations strongly influence the onset of cancer. Likewise, neurodegenerative diseases may often begin from somatically mutated cells. If so, both neurodegeneration and cancer may be diseases of later life for which much of the risk may be set by early life somatic mutations.

[1]  R. Happle Type 2 segmental Cowden disease vs. Proteus syndrome , 2007, The British journal of dermatology.

[2]  E. Luebeck,et al.  Gestational mutations and carcinogenesis. , 2005, Mathematical biosciences.

[3]  S. Frank Somatic evolutionary genomics: Mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration , 2010, Proceedings of the National Academy of Sciences.

[4]  Michael P. Snyder,et al.  Extensive genetic variation in somatic human tissues , 2012, Proceedings of the National Academy of Sciences.

[5]  J. Lupski Genome Mosaicism—One Human, Multiple Genomes , 2013, Science.

[6]  Mathias Jucker,et al.  Self-propagation of pathogenic protein aggregates in neurodegenerative diseases , 2013, Nature.

[7]  Lucio Luzzatto,et al.  A quantitative measurement of the human somatic mutation rate. , 2005, Cancer research.

[8]  S. Frank Age-specific incidence of inherited versus sporadic cancers: a test of the multistage theory of carcinogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  T. Cole,et al.  Epidermal naevus in Proteus syndrome showing loss of heterozygosity for an inherited PTEN mutation , 2006, The British journal of dermatology.

[10]  M. Greaves In utero origins of childhood leukaemia. , 2005, Early human development.

[11]  J. Hall,et al.  Review and hypotheses: somatic mosaicism: observations related to clinical genetics. , 1988, American journal of human genetics.

[12]  R. Weinberg,et al.  The Biology of Cancer , 2006 .

[13]  C. Walsh,et al.  Somatic Mutation, Genomic Variation, and Neurological Disease , 2013, Science.

[14]  Lenore K. Beitel,et al.  Selection and mutation in the “new” genetics: an emerging hypothesis , 2010, Human Genetics.

[15]  S. Frank Dynamics of Cancer: Incidence, Inheritance, and Evolution , 2007 .

[16]  William Wheeler,et al.  Detectable clonal mosaicism and its relationship to aging and cancer , 2012, Nature Genetics.

[17]  R. Happle Mosaicism in Human Skin , 2014 .

[18]  Y. Shirakata,et al.  A Japanese case of segmental Darier's disease caused by mosaicism for the ATP2A2 mutation , 2003, The British journal of dermatology.

[19]  I. Ferrer,et al.  Somatic mosaicism in a case of apparently sporadic Creutzfeldt‐Jakob disease carrying a de novo D178N mutation in the PRNP gene , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[20]  Ira M. Hall,et al.  Mosaic Copy Number Variation in Human Neurons , 2013, Science.

[21]  D. Ashley Colonic cancer arising in polyposis coli. , 1969, Journal of medical genetics.

[22]  Evan Z. Macosko,et al.  Exploring the variation within , 2012, Nature Genetics.

[23]  C. Armon Acquired nucleic acid changes may trigger sporadic amyotrophic lateral sclerosis , 2005, Muscle & nerve.

[24]  T. Gasser,et al.  Parkinson's disease: Is it all in the genes? , 2013, Movement disorders : official journal of the Movement Disorder Society.

[25]  Evan E Eichler,et al.  Properties and rates of germline mutations in humans. , 2013, Trends in genetics : TIG.

[26]  M. Gerstein,et al.  Somatic copy-number mosaicism in human skin revealed by induced pluripotent stem cells , 2012, Nature.

[27]  Martin A. Nowak,et al.  Cell biology: Developmental predisposition to cancer , 2003, Nature.

[28]  A. Knudson Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Ingo Ruczinski,et al.  Detectable clonal mosaicism from birth to old age and its relationship to cancer , 2012, Nature Genetics.

[30]  S. Prusiner,et al.  A Unifying Role for Prions in Neurodegenerative Diseases , 2012, Science.

[31]  R. Pyeritz,et al.  Human genetics and disease: Mechanisms and consequences of somatic mosaicism in humans , 2002, Nature Reviews Genetics.

[32]  Steven A Frank,et al.  Somatic mosaicism and cancer: inference based on a conditional Luria-Delbrück distribution. , 2003, Journal of theoretical biology.

[33]  D. Kulenkampff,et al.  Die Elephantiastischen Formen : eine umfassende Darstellung der angeborenen und erworbenen Elephantiasis sowie aller verwandten Leiden , 1885 .

[34]  A. Hovnanian,et al.  Mosaicism for ATP2A2 mutations causes segmental Darier's disease. , 2000, The Journal of investigative dermatology.

[35]  A. Schapira,et al.  Somatic Alpha-Synuclein Mutations in Parkinson's Disease: Hypothesis and Preliminary Data , 2013, Movement disorders : official journal of the Movement Disorder Society.

[36]  S. Prusiner,et al.  Transmission of multiple system atrophy prions to transgenic mice , 2013, Proceedings of the National Academy of Sciences.

[37]  J. Mattick,et al.  RNAs as extracellular signaling molecules. , 2008, Journal of molecular endocrinology.

[38]  F. Real,et al.  Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome , 2012, Nature Genetics.

[39]  J. Hutchinson,et al.  Developmental predisposition to cancer , 2003 .